Previous close | 9.63 |
Open | 9.57 |
Bid | 9.13 x 145200 |
Ask | 9.35 x 140700 |
Day's range | 9.17 - 10.16 |
52-week range | 9.17 - 24.36 |
Volume | |
Avg. volume | 464 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 22 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Evotec ( ETR:EVT ) Full Year 2023 Results Key Financial Results Revenue: €781.4m (up 4.0% from FY 2022). Net loss...
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration agreement to identify a best-in-class treatment for diseases caused by fibrosis.
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...